000 | 01019 a2200313 4500 | ||
---|---|---|---|
005 | 20250516191830.0 | ||
264 | 0 | _c20140725 | |
008 | 201407s 0 0 eng d | ||
022 | _a1750-7448 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNagda, Priti | |
245 | 0 | 0 |
_aImplantable melanoma vaccine enters human clinical trials. _h[electronic resource] |
260 |
_bImmunotherapy _cDec 2013 |
||
300 |
_a1277 p. _bdigital |
||
500 | _aPublication Type: News | ||
650 | 0 | 4 | _aAbsorbable Implants |
650 | 0 | 4 |
_aCancer Vaccines _ximmunology |
650 | 0 | 4 |
_aCell Transplantation _xmethods |
650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
650 | 0 | 4 |
_aCytotoxicity, Immunologic _ximmunology |
650 | 0 | 4 | _aGenetic Techniques |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmune System _xcytology |
650 | 0 | 4 |
_aImmunotherapy, Adoptive _xmethods |
650 | 0 | 4 |
_aMelanoma _ximmunology |
650 | 0 | 4 |
_aSkin Neoplasms _ximmunology |
650 | 0 | 4 | _aTransplantation, Autologous |
773 | 0 |
_tImmunotherapy _gvol. 5 _gno. 12 _gp. 1277 |
|
999 |
_c23447012 _d23447012 |